Ledger.Open graph →

SEC Form D · Amendment · filed July 28, 2014

Aeglea BioTherapeutics Holdings, LLC

Offering

$11.0M

Sold

$10.7M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

AUSTIN, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Walter V. Klemp · Houston, TXExec · Director Lee C. Stranathan · Houston, TXExec · Director Christopher C. Capelli · Houston, TXExec · Director Samuel C. Wagner · San Diego, CADirector Dimitrios N. Theofilopoulos · San Diego, CADirector Thomas E. Ichim · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗